Oncolytics Biotech - 48 Year Dividend History | ONCY

Historical dividend payout and yield for Oncolytics Biotech (ONCY) since 1971. The current TTM dividend payout for Oncolytics Biotech (ONCY) as of June 21, 2019 is $0.00. The current dividend yield for Oncolytics Biotech as of June 21, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.035B $0.000B
Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $114.125B 12.90
Gilead Sciences (GILD) United States $88.452B 10.74
Bio-Techne Corp (TECH) United States $7.965B 54.34